DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

Dr Angelyn Bethel



Conference Abstracts (6 of 6)


Search Conference Abstracts :

2016

52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Impact of sitagliptin on cardiovascular and safety-related outcomes in insulin-treated type 2 diabetes: the TECOS experience
M.A. Bethel, S.S. Engel, J. Ding, R.G. Josse, R.R. Holman and the TECOS Study Group
Diabetologia 2016;59:Suppl 1:S369
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Estimated 10-year benefit for diabetes complication rates by 1% HbA1c decrements in people with type 2 diabetes and cardiovascular disease
S.A. Mostafa, R.R. Holman, R.L. Coleman, O. Agbaje, M.A. Bethel
Diabetologia 2016;59:Suppl 1:S543
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Sex differences in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
J.B. Green, J. Alfredsson, S.R. Stevens, S.D. Reed, D.K. McGuire, P.W. Armstrong, S.S. Engel, M.A. Bethel, F. Van de Werf, E.D. Peterson, R.R. Holman
Diabetologia 2016;59:Suppl 1:S544
[Abstract] [Poster]

2012

American Diabetes Association (ADA) Conference, Philadelphia, USA (Poster)
Positive Impact of Revised FDA Guidance on Clinical Trial Design in Diabetes
Bethel MA, Sourij H
Diabetes 2012;61:Supp 1:A264
[Abstract]
Diabetes UK Annual Professional Conference, Glasgow, UK (Poster)
A self-administered oral glucose tolerance test
MA Bethel, H Sourij, S White, L Tucker, I Kennedy, R Coleman, A Ring and RR Holman
Diabetic Medicine 2012;2012 Sup 1:47
[Poster]

2009

69th Scientific Session of the American Diabetes Association, New Orleans (Publication only)
Rationale and Design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Bethel MA, Green J, Califf RM, Holman RR
Diabetes 2009;59:Suppl 1:A555
[Abstract]